Skip to content

Sub-thalamic Nucleus Stimulation in Parkinson Disease

Sub-thalamic Nucleus Stimulation in Parkinson Disease: Comparison of a Two-steps Electrophysiological Approach Under Local and General Anesthesia and a One-step Approach Under General Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01817088
Acronym
PARKEO
Enrollment
30
Registered
2013-03-22
Start date
2013-03-11
Completion date
2016-09-09
Last updated
2017-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Deep Brain Stimulation (DBS), Parkinson disease, Stereotaxis Technique, Subthalamic nucleus

Brief summary

Deep brain stimulation (DBS) is an established procedure for the symptomatic treatment of Parkinson's disease. This procedure performed in two steps using electrophysiology. This study is a prospective, randomized and monocentric study to compare two DBS procedures with or without electrophysiology. A better control of targeting and trajectory is necessary before not using electrophysiology, which is the reference procedure. A new definition of sub thalamic nuclei with new MRI stereotactic landmarks, the use of surgical robot (Neuromata Renishaw) and the use of operative imaging (O-arm) could allow the implantation of electrode in sub-thalamic nuclei without the need of electrophysiology. Two groups of patients will be followed: a first group of patients with a procedure under general anesthesia alone without electrophysiological stimulation and a second smaller group of patients with a first step of electrode implantation under awake surgery with electrophysiological stimulation followed by a second step under general anesthesia for the implantation of stimulator. Clinical results will be assessed at 6 months after implantation.

Detailed description

Deep brain stimulation (DBS) is an established procedure for the symptomatic treatment of Parkinson's disease. This procedure performed in two steps using electrophysiology (Limousin et al., 1995) to register the activity of the sub-thalamic nucleus and test the efficacy of stimulation while the patient is awake. A second procedure is needed a few days later to implant the stimulation device under general anaesthesia. The duration of the first procedure is long because of a necessary time of deep stimulation to control the target before definitive implantation. Firstly, the long time of procedure causes pain for the patient. Secondly, the time of procedure, and thus of electrophysiology, is correlated with a rate of device infection of 5 % - 6 % (Hamani et al., 2006; Kenney et al., 2007; Sillay et al., 2008; Doshi et al., 2011). Thirdly, the introduction of several microelectrodes increases the risk of operative and postoperative haemorrhages, estimated at 1 % (Kenney et al., 2007; Sansur et al., 2007; Voges et al., 2007; Bhatia et al., 2008). Moreover, Foltynie et al. (2011) described 12/79 patients treated under general anaesthesia alone with the same post operative results than those who were firstly treated under local anaesthesia. A better control of targeting and trajectory is necessary before not using electrophysiology, which is the reference procedure. A new definition of sub thalamic nuclei with new MRI stereotactic landmarks, the use of surgical robot (Neuromata Renishaw) and the use of operative imaging (O-arm) could allow the implantation of electrode in sub-thalamic nuclei without the need of electrophysiology. (Caire et al. 2012, In press). This study is a prospective, randomized and monocentric study. The randomization will be made according to a ratio 2:1 in favour of the technique without electrophysiology. Two groups of patients will be followed: a first group of patients with a procedure under general anesthesia alone without electrophysiological stimulation and a second smaller group of patients with a first step of electrode implantation under awake surgery with electrophysiological stimulation followed by a second step under general anesthesia. After a preoperative assessment, a end-point evaluation at 6 months after implantation will complete the follow-up. The stimulation efficacy (UPDRS-3) and the post operative adverse effects will be noticed. This study will also evaluate the occurrence of a post-traumatic stress disorder (PTSD) in Parkinson disease patients operated under deep brain stimulation.

Interventions

PROCEDURENew targeting procedure without electrophysiology

It is a neurosurgical procedure of electrodes implantation in the sub thalamic nuclei under general anaesthesia using a new targeting procedure without electrophysiology.

PROCEDUREClassical neurosurgical procedure

It is a neurosurgical procedure of electrodes implantation in the sub thalamic nuclei under awake surgery with electrophysiological control. A second surgical step is performed to implant the subcutaneous stimulation device, under general anesthesia.

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age : between 18 and 70 years old * Parkinson disease in fluctuation state despite the use of an optimal medical treatment * Dopa sensibility higher than 50% with the L-DOPA test * Normal MRI * Mattis Scale \> 130 * Surgical indication approved by a multidisciplinary team * Patient covered by a social insurance * Informed consent signed by patient and investigator

Exclusion criteria

* Patients with surgical or anesthetic contraindications * Cerebral atrophy or signal abnormalities on MRI * Severe Depressive State : The Beck Scale score \> 15 * Women of childbearing potential without efficient contraceptive mean * Need of long-term antithrombotic treatment

Design outcomes

Primary

MeasureTime frameDescription
the ratio of preoperative and postoperative UPDRS 3 score6 monthThe primary outcome is defined after six months of sub-thalamic nucleus deep brain stimulation with the ratio of preoperative and postoperative UPDRS 3 score. The ratio is : (post operative UPDRS 3 OFF medicine and OFF stimulation- post operative UPDRS 3 OFF medicine ON stimulation)/(post operative UPDRS 3 OFF medicine OFF stimulation)

Secondary

MeasureTime frameDescription
The variance of improvement mean for the high precision technique6 monthThe variance of improvement mean for the high precision technique
Percentage of patients with an improvement of UPDRS III score6 monthPercentage of patients with an improvement of UPDRS III score of 35%, 50% et 65%
The Calculated preoperative and post operative (6 months) equivalent dose of L-DOPA and the decrease of between preoperative and post operative period (6 months).6 monthThe Calculated preoperative and post operative (6 months) equivalent dose of L-DOPA and the decrease of between preoperative and post operative period (6 months).
Percentage of patients with failure of the new surgical technique defined with an improvement of less than 35 % with the UPDRS 3 score and an electrode located more than 4 mm from the target6 monthPercentage of patients with failure of the new surgical technique defined with an improvement of less than 35 % with the UPDRS 3 score and an electrode located more than 4 mm from the target
Quality of Life6 monthQuality of Life scale : PDQ-39
Non motor items of UPDRS score in the high precision technique under general anesthesia alone6 monthNon motor items of UPDRS score in the high precision technique under general anesthesia alone
Adverse effects and complications6 monthAdverse effects and complications : infection, haemorrhages, paresthesia, hypophonia and dyskinesia
Stimulation efficacy6 monthEfficacy with the ratio : (Preoperative UPDRS 3 OFF medicine - post operative UPDRS 3 OFF medicine ON stimulation)/( preoperative UPDRS 3 OFF medicine )
Compare the technical feasibility for both surgeries based on the number of electrodes implanted in the targetafter surgeryCompare the technical feasibility for both surgeries based on the number of electrodes implanted in the target
Operative and postoperative surgical adverse effects.6 monthOperative and postoperative surgical adverse effects.
Evaluate the influence of two operative procedures on the onset and maintenance of post-operative PTSD6 monthEvaluate the influence of two operative procedures on the onset and maintenance of post-operative PTSD
Evaluate the influence of two operative procedures on the level of preoperative anxiety and the time course of this anxiety1, 3 and 6 monthEvaluate the influence of two operative procedures on the level of preoperative anxiety and the time course of this anxiety
Differentiate thymic and cognitive factors potentially predictors of the occurrence of post-surgical PTSD6 monthDifferentiate thymic and cognitive factors potentially predictors of the occurrence of post-surgical PTSD
Evaluate the long-term effects of the two operating procedures on thymic and cognitive state6 monthEvaluate the long-term effects of the two operating procedures on thymic and cognitive state
Evaluate the dose of irradiation received by patients during surgery in both proceduresDuring surgery
Percentage of improvement in patients with the reference technique6 monthPercentage of improvement in patients with the reference technique (electrophysiological approach in awake surgery)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026